After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

Bernstein SocGen Group adjusted its price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), increasing it slightly from $441.00 to $444.00 while maintaining a Market Perform rating. With a ...

Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Scalp oiling boosts hair growth by stimulating blood flow to the scalp. Bridgette Hill, a trichologist and scalp therapist, ...

Discover a recent study that has examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial ...

Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you're having issues with slow hair growth, thinning hair or a dry, itchy scalp, check out these products for getting your ...

While scalp acne might seem to be only an inconvenient condition to manage, treating it could be key to preventing future hair loss. “If untreated or neglected, grossly manifested or subclinical ...